| CAS No. | 343630-41-1 |
|---|
| Purity | >98% |
|---|
| Formula | C15H10BrF3N6O |
|---|
| Mol Weight | 427.179 |
|---|
| Color |
White to off-white |
|---|
| State | solid powder |
|---|
| Solubility | Soluble in DMSO 250 mg/mL |
|---|
| Shelf Life | >2 years if stored properly |
|---|
| Storage | Powder -20℃ 2 years; In solvent -20℃ 1 month; |
|---|
| Shipping | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
|---|
| |
|---|
| | |
|---|
| Reference: | [1]. Hansen RS, et al. In vivo effects of the IKr agonist NS3623 on cardiac electrophysiology of the guinea pig. J Cardiovasc Pharmacol. 2008 Jul;52(1):35-41.
[2]. Diness JG, et al. Antiarrhythmic effect of IKr activation in a cellular model of LQT3. Heart Rhythm. 2009 Jan;6(1):100-6.
[3]. Calloe K, et al. A dual potassium channel activator improves repolarization reserve and normalizes ventricular action potentials. Biochem Pharmacol. 2016 May 15;108:36-46. |
|---|
| CoA | CoA of NS3623 |
|---|